The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.
about
Human cytomegalovirus IE1 promoter/enhancer drives variable gene expression in all fiber types in transgenic mouse skeletal muscleMonitoring immediate-early gene expression through firefly luciferase imaging of HRS/J hairless micePolymers for improving the in vivo transduction efficiency of AAV2 vectorsFlip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.In vivo electroporation mediated gene delivery to the beating heart.Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells.Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus.Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer.Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter.Kinetics of recombinant adeno-associated virus-mediated gene transfer.In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirusAllogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latencyMarkedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp.Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon systemEndogenous Myc maintains the tumor microenvironment.Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector.Irradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: implementation of non-invasive fluorescence imaging.Brief expression of a GFP cre fusion gene in embryonic stem cells allows rapid retrieval of site-specific genomic deletionsAn essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis.Tracking an embryonic L1 retrotransposition eventModelling Myc inhibition as a cancer therapy.Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA.Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.Evaluation of lentiviral-mediated expression of sodium iodide symporter in anaplastic thyroid cancer and the efficacy of in vivo imaging and therapyDifferential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirusMurine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic miceDevelopmental analysis of the cytomegalovirus enhancer in transgenic animals.Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector.Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.Development of an epithelium-specific expression cassette with human DNA regulatory elements for transgene expression in lung airways.In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation.Transgenic mouse with the herpes simplex virus type 1 latency-associated gene: expression and function of the transgeneEfficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors.The transgenic ICP4 promoter is activated in Schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1.The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infectionRegulated gene expression in the chicken embryo by using replication-competent retroviral vectors.Neurons differentially activate the herpes simplex virus type 1 immediate-early gene ICP0 and ICP27 promoters in transgenic mice.
P2860
Q24795634-47E9DA6B-11F9-4B4B-9919-D1E5EB9E2B71Q24799895-E95ED851-5AD3-4D8F-AD7A-1F7C5E76A7C3Q27438107-10141354-C5C7-4A99-ABEB-2D47CA756B72Q30826113-53006DA3-7111-462C-953D-95C5A9BE35C3Q30994484-E04A1A69-6E76-479A-932E-22D7882746CDQ33781921-E086985A-7089-479E-80E1-E954888552A4Q33781947-40F289CE-5467-4CA7-A33F-A81A7F1FBC50Q33783897-43AF895D-1DE3-4ED9-9D90-358AE368C8E4Q33785172-3FEE31CE-2EAD-4538-A40B-9FB543D6D65BQ33800239-84824375-707D-4457-B0C3-0D5F246CE208Q33802149-E39A20C9-B3D6-46A9-B32A-634E183DA8A8Q33814326-F1C5F55A-1D70-4A04-9FB8-EE60D9F73D3EQ33841123-3CB86B70-6B2C-450B-9D2F-9F36994917C9Q33842432-232314CB-0BD1-4EB6-BF21-A76079EDC12EQ33888773-8556093A-8E85-4F0B-82D6-48DFFA47D41EQ34177033-3D56F535-CC69-4E01-86F8-9ECC3F15D4C6Q34209749-CA050A85-F9A7-442B-9422-43745AC5FF45Q34500991-838C7ED9-C676-478A-8737-9B9641FD70E5Q34633626-B6E1389C-BE44-4D55-80B1-ABB0D6EF350BQ34755471-CE0F8DA5-C9A5-410B-98D3-60F74C13210EQ34762192-5B29EEF0-268C-4C6A-8A24-9E0BDE7DECD0Q34811008-879D248F-C8C0-4EA7-9272-42CC8036F748Q35102017-2F0D7B8A-120B-4038-9C71-6E5C856E6A74Q35623662-B468F6DC-74EE-490F-B775-6CF2D966AC07Q35636298-B2B883CD-A8BA-4545-835B-756C20B5B977Q35764082-0A9DC9B2-F317-46EC-8024-9E506465D906Q35786286-1FB9D484-72F1-48A9-BB35-2B9FCAB74110Q35860583-ED12476E-47D8-49D2-A1D4-8980B8AA454AQ35891440-D3D107AC-99C2-4C44-9E75-B6299FE1BE1FQ36688075-481114FA-DDC3-4625-B74B-71A5E786D9AEQ36830265-93FCEB58-81F5-493C-92BF-98F3D0A68DDFQ36934017-54D1FA69-1CAF-4680-A16B-9CEF5042637FQ37059659-EC1C3E56-2AA1-437D-83BC-1BF6D7F898CDQ37251114-38B0F252-6833-4E70-8465-A7C12B1602C2Q37303897-487A2159-FCB5-4F8D-9E65-D21959750AAAQ39595568-D12D9C4E-B61A-4C99-9945-F60B46E72D96Q39604733-EB2E85F6-FAC9-48DF-9EF6-BD9EF1824A26Q39627859-1D6EA44B-78E2-465B-B26D-9B2559E248B2Q39682559-025E19D7-565D-434B-A0C5-D3F9DBFA9350Q39748037-31D9FDD4-DDCD-49F0-B5C3-714EDD562E28
P2860
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The enhancer domain of the hum ...... expression in transgenic mice.
@ast
The enhancer domain of the hum ...... expression in transgenic mice.
@en
type
label
The enhancer domain of the hum ...... expression in transgenic mice.
@ast
The enhancer domain of the hum ...... expression in transgenic mice.
@en
prefLabel
The enhancer domain of the hum ...... expression in transgenic mice.
@ast
The enhancer domain of the hum ...... expression in transgenic mice.
@en
P2093
P2860
P1433
P1476
The enhancer domain of the hum ...... expression in transgenic mice.
@en
P2093
A M Colberg-Poley
D J Tenney
J A Nelson
J F Baskar
N J Peffer
S Hoffmann
P2860
P304
P407
P577
1996-05-01T00:00:00Z